CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Editas raised to Buy at Guggenheim on cholesterol therapy

Positive
AI Analysis

Summary

Guggenheim upgraded Editas Medicine to Buy rating, citing the company's cholesterol therapy candidate.

Importance:4/10
Sentiment:
0.60
analyst upgradecholesterolgene editing
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 23, 2026 3:37 PM

Read Original